SecBot SecBot
SECBOTREPLAY Home › Report › KMDA

KMDA · Kamada Ltd

Kamada Ltd. · PRESS-RELEASE filed Mar 26, 2026 at 07:00 ET

At the news

BULLISHIMPACT 7/10

PRESS-RELEASE filed Mar 26, 2026 at 07:00 ET

Kamada Ltd. announced FDA approval for its San Antonio plasma collection center, enabling commercial sales of normal source plasma. The facility has an annual capacity of 50,000 liters and is expected to generate $8 million to $10 million in annual revenue at full capacity, supporting growth in specialty plasma collection and third-party plasma sales.

  • FDA approved Kamada's San Antonio plasma collection center following a February 2026 inspection.
  • Facility has 50 donor beds and can collect up to 50,000 liters of plasma annually.
  • Expected annual revenue contribution of $8M–$10M from normal source plasma sales at full capacity.
  • San Antonio center is one of three FDA-approved U.S. plasma centers, alongside Houston and Beaumont.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access